Clinical Trials Browser

Withdrawn × Adenocarcinoma × Docetaxel × Clear all

NCT01685489 2015-10-27

A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer

Phase 1 Withdrawn

Adenocarcinoma, Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms